244 related articles for article (PubMed ID: 27005704)
1. Prohibitin-induced, obesity-associated insulin resistance and accompanying low-grade inflammation causes NASH and HCC.
Ande SR; Nguyen KH; Grégoire Nyomba BL; Mishra S
Sci Rep; 2016 Mar; 6():23608. PubMed ID: 27005704
[TBL] [Abstract][Full Text] [Related]
2. Prohibitin - At the crossroads of obesity-linked diabetes and cancer.
Mishra S; Nyomba BG
Exp Biol Med (Maywood); 2017 Jun; 242(11):1170-1177. PubMed ID: 28399645
[TBL] [Abstract][Full Text] [Related]
3. Gonadectomy in Mito-Ob mice revealed a sex-dimorphic relationship between prohibitin and sex steroids in adipose tissue biology and glucose homeostasis.
Xu YXZ; Ande SR; Mishra S
Biol Sex Differ; 2018 Aug; 9(1):37. PubMed ID: 30157935
[TBL] [Abstract][Full Text] [Related]
4. Obesity-related abnormalities couple environmental triggers with genetic susceptibility in adult-onset T1D.
Nguyen KH; Ande SR; Mishra S
Biochem Biophys Res Commun; 2016 Jan; 470(1):94-100. PubMed ID: 26766792
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic Steatohepatitis and HCC in a Hyperphagic Mouse Accelerated by Western Diet.
Ganguly S; Muench GA; Shang L; Rosenthal SB; Rahman G; Wang R; Wang Y; Kwon HC; Diomino AM; Kisseleva T; Soorosh P; Hosseini M; Knight R; Schnabl B; Brenner DA; Dhar D
Cell Mol Gastroenterol Hepatol; 2021; 12(3):891-920. PubMed ID: 34062281
[TBL] [Abstract][Full Text] [Related]
6. Histone Deacetylase HDAC8 Promotes Insulin Resistance and β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma.
Tian Y; Wong VW; Wong GL; Yang W; Sun H; Shen J; Tong JH; Go MY; Cheung YS; Lai PB; Zhou M; Xu G; Huang TH; Yu J; To KF; Cheng AS; Chan HL
Cancer Res; 2015 Nov; 75(22):4803-16. PubMed ID: 26383163
[TBL] [Abstract][Full Text] [Related]
7. Obesity, insulin resistance, NASH and hepatocellular carcinoma.
Yu J; Shen J; Sun TT; Zhang X; Wong N
Semin Cancer Biol; 2013 Dec; 23(6 Pt B):483-91. PubMed ID: 23876851
[TBL] [Abstract][Full Text] [Related]
8. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC.
Grohmann M; Wiede F; Dodd GT; Gurzov EN; Ooi GJ; Butt T; Rasmiena AA; Kaur S; Gulati T; Goh PK; Treloar AE; Archer S; Brown WA; Muller M; Watt MJ; Ohara O; McLean CA; Tiganis T
Cell; 2018 Nov; 175(5):1289-1306.e20. PubMed ID: 30454647
[TBL] [Abstract][Full Text] [Related]
9. A Regulatory Role of Apoptosis Antagonizing Transcription Factor in the Pathogenesis of Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma.
Kumar DP; Santhekadur PK; Seneshaw M; Mirshahi F; Uram-Tuculescu C; Sanyal AJ
Hepatology; 2019 Apr; 69(4):1520-1534. PubMed ID: 30394550
[TBL] [Abstract][Full Text] [Related]
10. PPARα-Deficient ob/ob Obese Mice Become More Obese and Manifest Severe Hepatic Steatosis Due to Decreased Fatty Acid Oxidation.
Gao Q; Jia Y; Yang G; Zhang X; Boddu PC; Petersen B; Narsingam S; Zhu YJ; Thimmapaya B; Kanwar YS; Reddy JK
Am J Pathol; 2015 May; 185(5):1396-408. PubMed ID: 25773177
[TBL] [Abstract][Full Text] [Related]
11. Hepatic Oncostatin M Receptor β Regulates Obesity-Induced Steatosis and Insulin Resistance.
Luo P; Wang PX; Li ZZ; Zhang XJ; Jiang X; Gong J; Qin JJ; Guo J; Zhu X; Yang S; Li H
Am J Pathol; 2016 May; 186(5):1278-92. PubMed ID: 26976243
[TBL] [Abstract][Full Text] [Related]
12. [Cellular senescence and chronic inflammation].
Ohtani N
Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(5):390-7. PubMed ID: 25744638
[TBL] [Abstract][Full Text] [Related]
13. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
14. Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development.
Jiang CM; Pu CW; Hou YH; Chen Z; Alanazy M; Hebbard L
World J Gastroenterol; 2014 Nov; 20(44):16464-73. PubMed ID: 25469014
[TBL] [Abstract][Full Text] [Related]
15. Expression of a mutant prohibitin from the aP2 gene promoter leads to obesity-linked tumor development in insulin resistance-dependent manner.
Ande SR; Nguyen KH; Padilla-Meier GP; Nyomba BL; Mishra S
Oncogene; 2016 Aug; 35(34):4459-70. PubMed ID: 26751773
[TBL] [Abstract][Full Text] [Related]
16. Sodium alginate prevents progression of non-alcoholic steatohepatitis and liver carcinogenesis in obese and diabetic mice.
Miyazaki T; Shirakami Y; Kubota M; Ideta T; Kochi T; Sakai H; Tanaka T; Moriwaki H; Shimizu M
Oncotarget; 2016 Mar; 7(9):10448-58. PubMed ID: 26871288
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play.
Charrez B; Qiao L; Hebbard L
World J Gastroenterol; 2016 Feb; 22(8):2494-502. PubMed ID: 26937137
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma.
Gomes AL; Teijeiro A; Burén S; Tummala KS; Yilmaz M; Waisman A; Theurillat JP; Perna C; Djouder N
Cancer Cell; 2016 Jul; 30(1):161-175. PubMed ID: 27411590
[TBL] [Abstract][Full Text] [Related]
19. The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation.
Chung HK; Kim YK; Park JH; Ryu MJ; Chang JY; Hwang JH; Lee CH; Kim SH; Kim HJ; Kweon GR; Kim KS; Shong M
Liver Int; 2015 Apr; 35(4):1341-53. PubMed ID: 25443620
[TBL] [Abstract][Full Text] [Related]
20. Gp78, an E3 ubiquitin ligase acts as a gatekeeper suppressing nonalcoholic steatohepatitis (NASH) and liver cancer.
Zhang T; Kho DH; Wang Y; Harazono Y; Nakajima K; Xie Y; Raz A
PLoS One; 2015; 10(3):e0118448. PubMed ID: 25789613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
